Shares of Biocon Ltd. gained on Thursday, October 23, after the company said its subsidiary Biocon Biologics has received approval from Health Canada for...
Drug firm Zydus Lifesciences Limited on Wednesday (October 1) said its US subsidiary, Sentynl Therapeutics, Inc., has received a Complete Response Letter (CRL) from...